2018. In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis. ADMET and DMPK. 6, 2 (Jun. 2018), 176–189. DOI:https://doi.org/10.5599/admet.547.